|
Diabetes, Vol 45, Issue 2 242-256, Copyright © 1996 by American Diabetes Association
Report of the American Diabetes Association's Task Force on standardization of the insulin assay
DC Robbins, L Andersen, R Bowsher, R Chance, B Dinesen, B Frank, R Gingerich, D Goldstein, HM Widemeyer, S Haffner, CN Hales, L Jarett, K Polonsky, D Porte, J Skyler, G Webb and K Gallagher
Penn Medical Laboratory, Medlantic Research Institute, Washington, DC 20010, USA.
Recent large-scale epidemiological studies demonstrate that blood
concentrations of immunoreactive insulin predict the development of NIDDM
and IDDM and are associated with the risk of several degenerative diseases,
such as coronary and peripheral vessel atherosclerosis, hypertension, and
dyslipidemia. The reliability of these measurements is dependent on a
biological assay that has not been well standardized between laboratories.
Recognizing this, the American Diabetes Association organized a task force
to assess comparability of blood insulin measurements between laboratories
and to suggest techniques to improve comparability. The task force found
that identical serum and plasma samples measured in different laboratories
produced widely disparate values that were unacceptable for population
comparisons. Use of a single reference standard did little to improve
comparability. Assay characteristics such as linearity, recovery, accuracy,
and cross-reactivity to proinsulin and its primary conversion intermediates
varied among the laboratories, and they did not readily explain differences
in the measurements made from assay to assay. Use of the same assay kit in
different laboratories did not always ensure comparable measurements.
Linear regression of assay results from one laboratory to an arbitrarily
chosen reference assay greatly improved comparability and demonstrated the
potential value in comparing each assay to a reference method. The task
force report defines acceptable assay characteristics and proposes a
three-step process of insulin assay proficiency and comparability. A
central reference assay and ongoing sample exchange will be needed to allow
reliable comparisons of insulin measurements made in different
laboratories. Rigorous quality control and continuous quality improvement
are needed to maintain reliability of the insulin measurement.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Rodriguez-Cabaleiro, K. Van Uytfanghe, V. Stove, T. Fiers, and L. M. Thienpont
Pilot Study for the Standardization of Insulin Immunoassays with Isotope Dilution Liquid Chromatography/Tandem Mass Spectrometry
Clin. Chem.,
August 1, 2007;
53(8):
1462 - 1469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J.G. Hanley, L. E. Wagenknecht, A. Festa, R. B. D'Agostino Jr., and S. M. Haffner
Alanine Aminotransferase and Directly Measured Insulin Sensitivity in a Multiethnic Cohort: The Insulin Resistance Atherosclerosis Study
Diabetes Care,
July 1, 2007;
30(7):
1819 - 1827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sapin
Insulin Immunoassays: Fast Approaching 50 Years of Existence and Still Calling for Standardization
Clin. Chem.,
May 1, 2007;
53(5):
810 - 812.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Manley, I. M. Stratton, P. M. Clark, and S. D. Luzio
Comparison of 11 Human Insulin Assays: Implications for Clinical Investigation and Research
Clin. Chem.,
May 1, 2007;
53(5):
922 - 932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Marcovina, R. R. Bowsher, W. G. Miller, M. Staten, G. Myers, S. P. Caudill, S. E. Campbell, M. W. Steffes, and for the Insulin Standardization Workgroup
Standardization of Insulin Immunoassays: Report of the American Diabetes Association Workgroup
Clin. Chem.,
April 1, 2007;
53(4):
711 - 716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hansen, T. Drivsholm, S. A. Urhammer, R. T. Palacios, A. Volund, K. Borch-Johnsen, and O. Pedersen
The BIGTT Test: A novel test for simultaneous measurement of pancreatic {beta}-cell function, insulin sensitivity, and glucose tolerance
Diabetes Care,
February 1, 2007;
30(2):
257 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Ford, C. Li, G. Imperatore, and S. Cook
Age, Sex, and Ethnic Variations in Serum Insulin Concentrations Among U.S. Youth: Findings from the National Health and Nutrition Examination Survey 1999-2002
Diabetes Care,
December 1, 2006;
29(12):
2605 - 2611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Li, E. S. Ford, L. C. McGuire, A. H. Mokdad, R. R. Little, and G. M. Reaven
Trends in hyperinsulinemia among nondiabetic adults in the u.s.
Diabetes Care,
November 1, 2006;
29(11):
2396 - 2402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Lee, M. J. Okumura, M. M. Davis, W. H. Herman, and J. G. Gurney
Prevalence and Determinants of Insulin Resistance Among U.S. Adolescents: A population-based study.
Diabetes Care,
November 1, 2006;
29(11):
2427 - 2432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Moriyama, N. Hayashi, C. Ohyabu, M. Mukai, S. Kawano, and S. Kumagai
Performance Evaluation and Cross-Reactivity from Insulin Analogs with the ARCHITECT Insulin Assay,
Clin. Chem.,
July 1, 2006;
52(7):
1423 - 1426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mohlig, J. Spranger, M. Ristow, A. F H Pfeiffer, T. Schill, H. W Schlosser, L. Moltz, G. Brabant, and C. Schofl
Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome
Eur. J. Endocrinol.,
February 1, 2006;
154(2):
295 - 301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Toffolo, M. Campioni, R. Basu, R. A. Rizza, and C. Cobelli
A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction
Am J Physiol Endocrinol Metab,
January 1, 2006;
290(1):
E169 - E176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kahn, J. Buse, E. Ferrannini, and M. Stern
The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care,
September 1, 2005;
28(9):
2289 - 2304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ferrannini, S. Camastra, A. Gastaldelli, A. Maria Sironi, A. Natali, E. Muscelli, G. Mingrone, and A. Mari
Beta-Cell Function in Obesity: Effects of Weight Loss
Diabetes,
December 1, 2004;
53(suppl_3):
S26 - S33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Luchsinger, M.-X. Tang, S. Shea, and R. Mayeux
Hyperinsulinemia and risk of Alzheimer disease
Neurology,
October 12, 2004;
63(7):
1187 - 1192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Wallace, J. C. Levy, and D. R. Matthews
Use and Abuse of HOMA Modeling
Diabetes Care,
June 1, 2004;
27(6):
1487 - 1495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Golla and R. Seethala
A Sensitive, Robust High-Throughput Electrochemiluminescence Assay for Rat Insulin
J Biomol Screen,
February 1, 2004;
9(1):
62 - 70.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sheeder, S. H. Travers, and C. Stevens-Simon
Is This Patient Insulin Resistant? How Much Does It Matter?
Clinical Pediatrics,
November 1, 2003;
42(9):
835 - 839.
[PDF]
|
 |
|

|
 |

|
 |
 
D. Komninou, A. Ayonote, J. P. Richie Jr., and B. Rigas
Insulin Resistance and Its Contribution to Colon Carcinogenesis
Experimental Biology and Medicine,
April 1, 2003;
228(4):
396 - 405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. T. Bloomgarden
American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome: 25-26 August 2002, Washington, DC
Diabetes Care,
March 1, 2003;
26(3):
933 - 939.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Arslanian, R. Saad, V. Lewy, K. Danadian, and J. Janosky
Hyperinsulinemia in African-American Children: Decreased Insulin Clearance and Increased Insulin Secretion and Its Relationship to Insulin Sensitivity
Diabetes,
October 1, 2002;
51(10):
3014 - 3019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Verma, C. M. Boney, R. Tucker, and B. R. Vohr
Insulin Resistance Syndrome in Women with Prior History of Gestational Diabetes Mellitus
J. Clin. Endocrinol. Metab.,
July 1, 2002;
87(7):
3227 - 3235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Haffner and A. J.G. Hanley
Do Increased Proinsulin Concentrations Explain the Excess Risk of Coronary Heart Disease in Diabetic and Prediabetic Subjects?
Circulation,
April 30, 2002;
105(17):
2008 - 2009.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Sacks, D. E. Bruns, D. E. Goldstein, N. K. Maclaren, J. M. McDonald, and M. Parrott
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
Clin. Chem.,
March 1, 2002;
48(3):
436 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Maggi, N. Minicuci, T. Harris, L. Motta, M. Baldereschi, A. Di Carlo, D. Inzitari, and G. Crepaldi
High Plasma Insulin and Lipids Profile in Older Individuals: The Italian Longitudinal Study on Aging
J. Gerontol. A Biol. Sci. Med. Sci.,
April 1, 2001;
56(4):
236M - 242.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Sapin, V. Le Galudec, F. Gasser, M. Pinget, and D. Grucker
Elecsys Insulin Assay: Free Insulin Determination and the Absence of Cross-Reactivity with Insulin Lispro,
Clin. Chem.,
March 1, 2001;
47(3):
602 - 605.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Kippen, F. Cerini, L. Vadas, R. Stocklin, L. Vu, R. E. Offord, and K. Rose
Development of an Isotope Dilution Assay for Precise Determination of Insulin, C-peptide, and Proinsulin Levels in Non-diabetic and Type II Diabetic Individuals with Comparison to Immunoassay
J. Biol. Chem.,
May 9, 1997;
272(19):
12513 - 12522.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Diabetes Association.
|
|
| |
|